市場調查報告書
商品編碼
1020432

DNA / RNA 提取試劑盒市場-增長、趨勢、COVID-19 影響和預測(2021-2026)

DNA/RNA Extraction Kit Market - Growth, Trends, COVID-19 Impact, and Forecas(2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

在 2021-2026 年的預測期內,DNA/RNA 提取試劑盒的市場規模預計將以 7.26% 的複合年增長率增長。

由於商業和研究活動有限,COVID-19 大流行對 DNA/RNA 提取試劑盒市場產生了短期影響。接受 COVID-19 檢測的患者人數減少也影響了在醫院和其他臨床診斷機構進行的其他疾病和醫學障礙的診斷檢測。然而,由於 COVID-19 的高感染率、各大公司對 SARS-CoV-2 病毒的分子診斷以及測序領域的研究活動以加深對病毒及其起源的認識,大量的 DNA 和RNA 開發並推出了基礎 COVID-19 試劑盒,這被證明非常重要,後來需求量很大。例如,2020 年 4 月,PHASE Scientific 宣佈商業推出用於檢測全球 COVID-19 病毒的 PHASIFY VIRAL RNA 提取試劑盒。

本報告探討了 DNA/RNA 提取試劑盒市場,並按產品、最終用戶、地區和進入市場的公司概況提供了市場概況、趨勢。

目錄

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場驅動力
    • 加大對分子診斷研發的投入
    • 技術進步
    • 癌症病例的患病率增加
  • 市場限制
    • 對套件缺乏認識
    • 市場滲透率低
  • 波特五力分析

第 5 章市場細分

  • 按產品
    • 無細胞 DNA
    • 序列特異性 DNA
    • 序列特異性 RNA
    • 總 RNA
    • 其他
  • 最終用戶
    • 醫院
    • 診斷中心
    • 研究所
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭形勢

  • 公司簡介
    • Qiagen
    • ThermoFisher Scientific Inc.
    • F. Hoffmann-La Roche AG
    • Agilent Technologies
    • Bio-Rad Laboratories, Inc.
    • Promega Corporation
    • Danaher Corporation(Beckman Coulter Inc.)
    • Merck &Co. Inc.
    • PerkinElmer Inc.
    • bioMerieux SA

第7章 市場機會動向

目錄
Product Code: 72137

The DNA/RNA extraction kit market is expected to register a CAGR of 7.26% during the forecast period of 2021-2026.

The COVID-19 pandemic impacted the DNA/RNA extraction kit market for the short time being due to restrictions on different business and research activities. Additionally, the diagnostics tests of other diseases and medical disorders in the hospitals and other clinical diagnostics establishments were affected due to a decrease in the turnout of the patients for tests because of COVID-19. However, the high infection rate of COVID-19 and research activities by key companies in the area of sequencing to expand their knowledge about the virus and its origin, along with molecular diagnostics of the SARS-CoV-2 virus, led to the development and launch of many DNA and RNA based COVID-19 kits, which proved to be very crucial and were in huge demand later. For instance, in April 2020, PHASE Scientific announced the commercial launch of the PHASIFY VIRAL RNA extraction kit for the detection of the COVID-19 virus, globally.

The major driving factor behind the growth of the DNA/RNA extraction kit market is the increasing investments in R&D activities in different fields, including molecular diagnostics for different chronic and infectious diseases. For example, according to the Organization for Economic Co-operation and Development, in 2018, the United States spent USD 552 billion on R&D activities, followed by China with USD 463 billion. The technological advancements, the launch of new products by the key market players, and rising cases of cancer, worldwide, may also complement the growth of the market studied. For instance, in June 2020, Omega Bio-tek Inc. announced the launch of an advanced viral RNA extraction kit for the COVID-19 testing, called Mag-Bind Viral RNA Xpress kit, for the efficient extraction of the Viral RNA from nasopharyngeal (NP) swab samples.

Other factors, such as increased demand in the automation of DNA/RNA extraction technology, new user-friendly and easy extraction kits, use of DNA/RNA in the profiling of new diseases causing microorganisms, are expected to boost the growth of the DNA/RNA extraction kit market during the forecast period. Thus, the low awareness and availability of the kits and less market penetration in the underdeveloped and developing regions, worldwide, are the major restraining factors for the growth of the DNA/RNA extraction kit market.

Key Market Trends

Extraction Kits for Cancer Patients for Diagnosis and Identification Will Occupy a Significant Share in the Market over the Forecast Period

A patient suffering from any kind of cancer, circulating cell-free DNA (ccfDNA), which originates from cancer cells, is found in the bloodstream, known as circulating tumor DNA (ctDNA). A very sensitive RNA and DNA extraction kits are used to isolate and profile them based on which treatment is performed on the patient. The companies are working toward it and developing and launching products related to the area. For instance, in May 2018, BioChain Institute Inc. launched a new cell-free DNA extraction kit, cfPure, for the efficient isolation and detection of circulating cell-free DNA (ccfDNA).

According to the International Agency for Research on Cancer (IARC) data released in December 2020, about 1 in 5 people develops cancer in their lifetime, and 1 in 8 men and 1 in 11 women die from cancer, globally. As per its updated GLOBOCAN 2020 report, in 2020, approximately 19.3 million new cancer cases were registered, worldwide, and 10 million people died from it. Therefore, the increasing prevalence of cancer may boost the growth of the DNA/RNA extraction kit market.

North America is Expected to Dominate the Global DNA/RNA Extraction Kit Market During the Forecast Period

North America holds a major share of the DNA/RNA extraction kit market and is expected to show a similar trend over the forecast period, mainly due to high R&D activities in the region, along with the presence of key market players in the area who are continuously evolving their product offering for the market studied.

In the region, the United States is expected to occupy the major share in the DNA/RNA extraction kit market due to huge investment in R&D by the government and private entities, increasing demand for the kits, and rising prevalence of chronic diseases, such as cancer. As per the GLOBOCAN 2020 report, around 2,281,658 new cancer cases in the United States were registered, and 612,390 patients died due to it. Additionally, the new product launches and other expansion initiatives of the market by the key market players in the area may boost the growth of the DNA/RNA extraction kit market. For instance, in February 2020, Promega Corporation announced the launch of a new DNA extraction kit, known as Wizard HMW DNA Extraction Kit, for extracting large fragments of DNA from any biological sample.

Competitive Landscape

The DNA/RNA extraction kit market will be very competitive due to the presence of different market players in all parts of the world, both local and multinational. The efficient and user-friendly kit may be in huge demand in the future, and the major driving force may be new developments and innovations in the following segment. The major market players of the DNA and RNA extraction kit market are as follows: Qiagen, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, F Hoffmann-La Roche AG, bioMerieux SA, and several others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Investments in R&D of Molecular Diagnostics
    • 4.2.2 Technological Advancements
    • 4.2.3 Increasing Prevalence of Cancer Cases
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness About the Kits
    • 4.3.2 Low Market Penetration
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Cell Free DNA
    • 5.1.2 Sequence Specific DNA
    • 5.1.3 Sequence Specific RNA
    • 5.1.4 Total RNA
    • 5.1.5 Other Products
  • 5.2 By End Users
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostics Centers
    • 5.2.3 Research Institutions
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Qiagen
    • 6.1.2 ThermoFisher Scientific Inc.
    • 6.1.3 F Hoffmann-La Roche AG
    • 6.1.4 Agilent Technologies
    • 6.1.5 Bio-Rad Laboratories Inc.
    • 6.1.6 Promega Corporation
    • 6.1.7 Danaher Corporation (Beckman Coulter Inc.)
    • 6.1.8 Merck & Co. Inc.
    • 6.1.9 PerkinElmer Inc.
    • 6.1.10 bioMerieux SA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS